HLB Life Science

067630 · KOSDAQ · Health Care · SMALL CAP

An acquisition.

HLB Life Science disclosed an acquisition of HLB Innovation Co., Ltd., worth US$26.1M.

M&A(Decision to acquire shares/equity in another company)· FILED 2026-08-28· RCEPT 20260828900545

US$26.1MDeal value
7.5%vs. company assets

Converted at 1 USD ≈ ₩1,380.45 (filing-date rate, 2026-08-27 close)

What happened

HLB Life Science disclosed an acquisition of HLB Innovation Co., Ltd., worth US$26.1M.

For context, this deal is worth about 7.5% of the company's own total assets.

TargetHLB Innovation Co., Ltd.
Deal valueUS$26.1M
vs. company assets7.5%
Filed2026-08-28, Decision to acquire shares/equity in another company
SourceDART rcept 20260828900545 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-08-28 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.